Covid19
+2
Russian Cardiovascular Registry of COVID-19
About this trial
Last updated 5 years ago
Study ID
0509-20-2020
Status
Unknown status
Type
Observational [Patient Registry]
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 3 years ago
What is this trial about?
This is a Russian multicenter observational study aimed to assess the mid-term and long-term
prognosis in patients recovered from COVID-19 with the involvement of the cardiovascular
system or with baseline severe cardiovascular diseases.
What are the participation requirements?
Inclusion Criteria
1. Age ≥18 years of age
2. Hospitalization with confirmed or suspected COVID-19 (ICD-10 codes U07.1 or U07.2)
3. Involvement of the cardiovascular system or baseline severe cardiovascular diseases defined as at least of the following:
- proven or suspected myocarditis;
- heart failure (NYHA functional class II-IV) before or during hospitalization with COVID-19;
- combination of COVID-19 with ACS or development of ACS during hospitalization with COVID-19 or performed percutaneous coronary intervention;
- proven pulmonary embolism;
- hemodynamically significant arrhythmias (atrial fibrillation, high-grade ventricular premature beats, paroxysmal ventricular arrhythmias), including those associated with the QT interval prolongation
Exclusion Criteria
- None
Locations
Location
Status
Recruiting